120
Participants
Start Date
September 21, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
EYE90 Microspheres Treatment
Y90 glass microspheres
RECRUITING
Weill Cornell Medicine-New York Presbyterian Hospital, New York
RECRUITING
Hospital of the University of Pennsylvania, Philadelphia
RECRUITING
Charlotte Radiology, Charlotte
RECRUITING
Emory University Hospital Midtown, Atlanta
RECRUITING
Piedmont Hospital, Atlanta
RECRUITING
AdventHealth Radiation Oncology at Altamonte Springs, Altamonte Springs
RECRUITING
Miami Cardiac and Vascular Institute at Baptist Hospital Miami, Miami
RECRUITING
HCA Healthcare Research Institute (Sarah Cannon), Nashville
RECRUITING
University of Louisville, Louisville
RECRUITING
University of Iowa Health Care, Iowa City
RECRUITING
Froedtert Hospital/Medical College of Wisconsin, Milwaukee
RECRUITING
Northwestern University Memorial Hospital, Chicago
RECRUITING
University of Illinois Hospital and Health Sciences System, Chicago
RECRUITING
SSM Health Saint Louis University, St Louis
RECRUITING
University of Missouri - Ellis Fischel Cancer Center, Columbia
RECRUITING
Ochsner Clinic Foundation, New Orleans
RECRUITING
University of Utah, Salt Lake City
RECRUITING
The University of Arizona Cancer Center, Tucson
RECRUITING
University of California - Irvine, Orange
RECRUITING
Inland Imaging, Spokane
RECRUITING
Beth Israel Deaconess, Boston
RECRUITING
Vancouver Coastal Health Research Institution (VCHRI), Vancouver
Lead Sponsor
ABK Biomedical
INDUSTRY